Financial statements Ośrodek Badań Farmaceutycznych I Klinicznych Biofana

Balance sheet of Ośrodek Badań Farmaceutycznych I Klinicznych Biofana

Company age:
Age:
21 y. 10 m. 22 d.
Share capital:
Share capital:
50 000 PLN
Profit and loss statement Balance Cash flow Profitability

Balance sheet data of OŚRODEK BADAŃ FARMACEUTYCZNYCH I KLINICZNYCH BIOFANA

Year
2023
Total assets 12 207 824,41
A. Fixed assets 2 615 534,46
B. Current assets 9 592 289,95
C. Share capital contributions (basic funds) 0,00
D. Own shares (stocks) 0,00
Total liabilities 12 207 824,41
A. Equity 9 695 164,95
B. Liabilities and provisions for liabilities 2 512 659,46
I. Long-term liabilities 0,00
II. Short-term liabilities 1 045 786,48
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.